Pancreatitis in hispanic patients with cystic fibrosis carrying the R334W mutation

Patrick Maisonneuve, Preston Campbell, Peter Durie, Albert B. Lowenfels

Research output: Contribution to journalArticle

Abstract

Background & Aims: Cystic fibrosis (CF) results from abnormal production of sticky mucus, which obstructs many organs. In most cases, the pancreas is severely compromised, but 10%-15% of patients with CF have pancreas sufficiency (PS) and are subject to develop pancreatitis. The aim of this study is to determine which specific genotypes lead to the development of pancreatitis in patients with CF. Methods: We used prospective data collected by the Cystic Fibrosis Foundation and performed a nested case-control study with all patients who reported at least 1 episode of pancreatitis constituting the cases. We used logistic regression to assess the association between pancreatitis and genotype and the Kaplan-Meier method to estimate the cumulative incidence of pancreatitis for selected genotypes. Results: Three hundred sixty-four of 17,871 genotyped patients with CF (2.0%) reported at least 1 episode of pancreatitis. Only 0.9% of 12,997 patients with genotypes generally associated with pancreas insufficiency reported pancreatitis against 11.9% of 868 patients carrying at least 1 mild CF mutation generally associated with PS. The greatest rate of pancreatitis (19.0%) was observed for patients carrying an R334W mutation: 48% of these 79 patients were Hispanic and 13 patients were living in Puerto Rico. Conclusions: Of all patients with CF, those carrying an R334W mutation have the greatest risk for developing pancreatitis. This mutation is found mostly in Hispanic patients with CF living in Puerto Rico. There are no current data to determine whether asymptomatic carriers of the R334W mutation are at greater risk for developing pancreatitis or whether this mutation is frequent in Hispanics with idiopathic pancreatitis.

Original languageEnglish
Pages (from-to)504-509
Number of pages6
JournalClinical Gastroenterology and Hepatology
Volume2
Issue number6
DOIs
Publication statusPublished - Jun 2004

Fingerprint

Hispanic Americans
Cystic Fibrosis
Pancreatitis
Mutation
Genotype
Pancreas
Puerto Rico
Mucus
Case-Control Studies
Logistic Models
Incidence

Keywords

  • CF
  • CFF
  • CFTR
  • CI
  • confidence interval
  • cystic fibrosis
  • Cystic Fibrosis Foundation
  • cystic fibrosis transmembrane conductance regulator
  • pancreas insufficiency
  • pancreas sufficiency
  • PI
  • PS

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Pancreatitis in hispanic patients with cystic fibrosis carrying the R334W mutation. / Maisonneuve, Patrick; Campbell, Preston; Durie, Peter; Lowenfels, Albert B.

In: Clinical Gastroenterology and Hepatology, Vol. 2, No. 6, 06.2004, p. 504-509.

Research output: Contribution to journalArticle

Maisonneuve, Patrick ; Campbell, Preston ; Durie, Peter ; Lowenfels, Albert B. / Pancreatitis in hispanic patients with cystic fibrosis carrying the R334W mutation. In: Clinical Gastroenterology and Hepatology. 2004 ; Vol. 2, No. 6. pp. 504-509.
@article{70020150893d4f8c8968c53c739ce3aa,
title = "Pancreatitis in hispanic patients with cystic fibrosis carrying the R334W mutation",
abstract = "Background & Aims: Cystic fibrosis (CF) results from abnormal production of sticky mucus, which obstructs many organs. In most cases, the pancreas is severely compromised, but 10{\%}-15{\%} of patients with CF have pancreas sufficiency (PS) and are subject to develop pancreatitis. The aim of this study is to determine which specific genotypes lead to the development of pancreatitis in patients with CF. Methods: We used prospective data collected by the Cystic Fibrosis Foundation and performed a nested case-control study with all patients who reported at least 1 episode of pancreatitis constituting the cases. We used logistic regression to assess the association between pancreatitis and genotype and the Kaplan-Meier method to estimate the cumulative incidence of pancreatitis for selected genotypes. Results: Three hundred sixty-four of 17,871 genotyped patients with CF (2.0{\%}) reported at least 1 episode of pancreatitis. Only 0.9{\%} of 12,997 patients with genotypes generally associated with pancreas insufficiency reported pancreatitis against 11.9{\%} of 868 patients carrying at least 1 mild CF mutation generally associated with PS. The greatest rate of pancreatitis (19.0{\%}) was observed for patients carrying an R334W mutation: 48{\%} of these 79 patients were Hispanic and 13 patients were living in Puerto Rico. Conclusions: Of all patients with CF, those carrying an R334W mutation have the greatest risk for developing pancreatitis. This mutation is found mostly in Hispanic patients with CF living in Puerto Rico. There are no current data to determine whether asymptomatic carriers of the R334W mutation are at greater risk for developing pancreatitis or whether this mutation is frequent in Hispanics with idiopathic pancreatitis.",
keywords = "CF, CFF, CFTR, CI, confidence interval, cystic fibrosis, Cystic Fibrosis Foundation, cystic fibrosis transmembrane conductance regulator, pancreas insufficiency, pancreas sufficiency, PI, PS",
author = "Patrick Maisonneuve and Preston Campbell and Peter Durie and Lowenfels, {Albert B.}",
year = "2004",
month = "6",
doi = "10.1016/S1542-3565(04)00170-3",
language = "English",
volume = "2",
pages = "504--509",
journal = "Clinical Gastroenterology and Hepatology",
issn = "1542-3565",
publisher = "W.B. Saunders Ltd",
number = "6",

}

TY - JOUR

T1 - Pancreatitis in hispanic patients with cystic fibrosis carrying the R334W mutation

AU - Maisonneuve, Patrick

AU - Campbell, Preston

AU - Durie, Peter

AU - Lowenfels, Albert B.

PY - 2004/6

Y1 - 2004/6

N2 - Background & Aims: Cystic fibrosis (CF) results from abnormal production of sticky mucus, which obstructs many organs. In most cases, the pancreas is severely compromised, but 10%-15% of patients with CF have pancreas sufficiency (PS) and are subject to develop pancreatitis. The aim of this study is to determine which specific genotypes lead to the development of pancreatitis in patients with CF. Methods: We used prospective data collected by the Cystic Fibrosis Foundation and performed a nested case-control study with all patients who reported at least 1 episode of pancreatitis constituting the cases. We used logistic regression to assess the association between pancreatitis and genotype and the Kaplan-Meier method to estimate the cumulative incidence of pancreatitis for selected genotypes. Results: Three hundred sixty-four of 17,871 genotyped patients with CF (2.0%) reported at least 1 episode of pancreatitis. Only 0.9% of 12,997 patients with genotypes generally associated with pancreas insufficiency reported pancreatitis against 11.9% of 868 patients carrying at least 1 mild CF mutation generally associated with PS. The greatest rate of pancreatitis (19.0%) was observed for patients carrying an R334W mutation: 48% of these 79 patients were Hispanic and 13 patients were living in Puerto Rico. Conclusions: Of all patients with CF, those carrying an R334W mutation have the greatest risk for developing pancreatitis. This mutation is found mostly in Hispanic patients with CF living in Puerto Rico. There are no current data to determine whether asymptomatic carriers of the R334W mutation are at greater risk for developing pancreatitis or whether this mutation is frequent in Hispanics with idiopathic pancreatitis.

AB - Background & Aims: Cystic fibrosis (CF) results from abnormal production of sticky mucus, which obstructs many organs. In most cases, the pancreas is severely compromised, but 10%-15% of patients with CF have pancreas sufficiency (PS) and are subject to develop pancreatitis. The aim of this study is to determine which specific genotypes lead to the development of pancreatitis in patients with CF. Methods: We used prospective data collected by the Cystic Fibrosis Foundation and performed a nested case-control study with all patients who reported at least 1 episode of pancreatitis constituting the cases. We used logistic regression to assess the association between pancreatitis and genotype and the Kaplan-Meier method to estimate the cumulative incidence of pancreatitis for selected genotypes. Results: Three hundred sixty-four of 17,871 genotyped patients with CF (2.0%) reported at least 1 episode of pancreatitis. Only 0.9% of 12,997 patients with genotypes generally associated with pancreas insufficiency reported pancreatitis against 11.9% of 868 patients carrying at least 1 mild CF mutation generally associated with PS. The greatest rate of pancreatitis (19.0%) was observed for patients carrying an R334W mutation: 48% of these 79 patients were Hispanic and 13 patients were living in Puerto Rico. Conclusions: Of all patients with CF, those carrying an R334W mutation have the greatest risk for developing pancreatitis. This mutation is found mostly in Hispanic patients with CF living in Puerto Rico. There are no current data to determine whether asymptomatic carriers of the R334W mutation are at greater risk for developing pancreatitis or whether this mutation is frequent in Hispanics with idiopathic pancreatitis.

KW - CF

KW - CFF

KW - CFTR

KW - CI

KW - confidence interval

KW - cystic fibrosis

KW - Cystic Fibrosis Foundation

KW - cystic fibrosis transmembrane conductance regulator

KW - pancreas insufficiency

KW - pancreas sufficiency

KW - PI

KW - PS

UR - http://www.scopus.com/inward/record.url?scp=2542585368&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2542585368&partnerID=8YFLogxK

U2 - 10.1016/S1542-3565(04)00170-3

DO - 10.1016/S1542-3565(04)00170-3

M3 - Article

C2 - 15181620

AN - SCOPUS:2542585368

VL - 2

SP - 504

EP - 509

JO - Clinical Gastroenterology and Hepatology

JF - Clinical Gastroenterology and Hepatology

SN - 1542-3565

IS - 6

ER -